Stock listing

NASDAQ:TERN Terns Pharmaceuticals, Inc. Stock

Home listing (NASDAQ) of Terns Pharmaceuticals, Inc.

Follow Terns Pharmaceuticals, Inc. into a list and get an email when it puts out news.

Terns Pharmaceuticals, Inc. logo
Ticker
NASDAQ:TERN
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All Terns Pharmaceuticals, Inc. news

Terns Pharmaceuticals, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
10 in the last 12 months · 120 in all · newest Sep 10, 2026 · oldest 2021
Decks
1 deck · latest Jun 14, 2021

Where Terns Pharmaceuticals, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:TERN · Home listing · This pageNASDAQUnited StatesUSD
gettex:430gettexGermanyEUR
LS Exchange:A2QNWRLS ExchangeGermanyEUR
Tradegate:430TradegateGermanyEUR
Lang & Schwarz:A2QNWRLang & SchwarzGermanyEUR
BOATS:TERNBOATSUnited StatesUSD
Stuttgart:430StuttgartGermanyEUR
Frankfurt:430FrankfurtGermanyEUR
Dusseldorf:430DusseldorfGermanyEUR
Hamburg:430HamburgGermanyEUR
Munich:430MunichGermanyEUR

Team and board

Officers

OfficerRole
Andrew GengosChief Financial Officer

Board

DirectorRole
Heather TurnerDirector
Robert AzelbyDirector

Decks

DeckKindSlidesDate
Technical Presentation (June 2021)Technical31 slidesJun 14, 2021

Open Decks

Financings

RaiseDate
Public offering of common stock
Closed: US$747.5M raised · US$40 a share · Jefferies +5
Dealers: Jefferies (co-lead), TD Cowen (co-lead), Leerink Partners (co-lead), Mizuho, Citizens Capital Markets, Oppenheimer & Co.
Use of proceeds: Research, clinical trials, development and manufacturing of product candidates including TERN-701, pre-launch activities, working capital and general purposes
Dec 11, 2025

Open Financings · Read by 6ix AI from the company's releases

Shareholders

Funds

HolderSharesValueAs of
AQR Small Cap Momentum Style Fund11,905US$628KMar 31, 2026

Insider trades

TradeTradeSharesPriceValueDate
Kuriakose Emil
Officer: Chief Medical Officer
Sale942USD 52.75US$49,691Apr 1, 2026

Big stakes

StakeStakeSharesDateFiling
BlackRock, Inc.6.80%5.74MDec 31, 2024Schedule 13G
Orbimed Advisors LLC4.80%4.24MNov 3, 2025Schedule 13D

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Robert Azelby
Other companies: Tango Therapeutics, Inc. (Chairman; Former President and CEO, Eliem Therapeutics, Inc. · Since at least Jun 19, 2026); Autolus Therapeutics plc (Director · Since at least Mar 18, 2026); Cardinal Health, Inc. (Director · Since at least Mar 1, 2024); ADC Therapeutics SA (Director · Since at least Jan 2, 2024); Aduro Biotech Inc (Director · Apr 10, 2023 – Aug 11, 2023 · Past); Climb Bio, Inc. (President & CEO, Director · Aug 9, 2021 – Oct 31, 2022 · Past); Immunomedics Inc (Director · Feb 26, 2020 – Oct 23, 2020 · Past); Clovis Oncology Inc (Director · Oct 11, 2018 – Jun 10, 2021 · Past); Alder BioPharmaceuticals Inc (President and CEO, Director · Jun 13, 2018 – Oct 22, 2019 · Past); Cascadian Therapeutics Inc (Director · Mar 31, 2017 – Mar 9, 2018 · Past); Juno Therapeutics Inc (EVP & Chief Commercial Officer · Nov 1, 2015 – Mar 5, 2018 · Past)
Director · Since at least Feb 20, 2025
Andrew Gengos
Other companies: Immuneering Corporation (Chief Financial Officer and Treasurer · Since at least Jul 16, 2026); Turn Therapeutics Inc. (Director · Since at least Oct 7, 2025); LeonaBio, Inc. (CFO and Chief Business Officer · May 18, 2023 – Sep 3, 2024 · Past); Cyteir Therapeutics Inc (Chief Business Officer · Jun 17, 2021 – Feb 22, 2022 · Past); Synlogic Inc (Chief Operating Officer · Oct 9, 2017 – Mar 14, 2018 · Past)
Chief Financial Officer · Since at least Feb 24, 2025
Heather Turner
Other companies: Avalyn Pharma Inc. (Director · Since at least Apr 29, 2026); LB Pharmaceuticals Inc (Chief Executive Officer, Director · Since at least Sep 10, 2025); Lyell Immunopharma, Inc. (Chief General Counsel · Jun 16, 2021 – Mar 16, 2022 · Past); Sangamo Therapeutics, Inc. (EVP, General Counsel & Sec. · Feb 12, 2018 – Feb 25, 2019 · Past); Atara Biotherapeutics, Inc. (Former EVP, GC & Sec. · Feb 6, 2018 – Feb 9, 2018 · Past)
Director · Since at least Nov 18, 2024
Jeffrey Kindler
Other companies: Praxis Precision Medicines, Inc. (Director · Since at least Jan 8, 2026); Precigen, Inc. (Director · Since at least Dec 28, 2023); Perrigo Company plc (Director · May 14, 2024 – May 14, 2025 · Past)
Director · Since at least Jun 10, 2024
Hongbo Lu
Other companies: Zenas BioPharma, Inc. (Director · Since at least Sep 12, 2024); Arrowhead Pharmaceuticals, Inc. (Director · Since at least Mar 15, 2024)
Director · Since at least Jun 10, 2024
Jill Quigley
Other companies: Chemomab Therapeutics Ltd. (Board Director · Since at least Jun 16, 2022); Passage Bio, Inc. (Chief Operating Officer · Feb 27, 2020 – Dec 8, 2021 · Past)
Director · Since at least Feb 4, 2021
Radhika Tripuraneni M.D.
Other companies: Viridian Therapeutics, Inc. (Chief Medical Officer · Since at least Feb 27, 2025); Prothena Corporation plc (Chief Development Officer · Feb 25, 2020 – Feb 23, 2022 · Past)
Director · Since at least Jul 26, 2022
Seokho Bryan Yoon
Other companies: LogicBio Therapeutics Inc (Chief Admin Officer & GC · Nov 11, 2019 – Apr 15, 2020 · Past); Nightstar Therapeutics PLC (General Counsel and Secretary · Jan 1, 2019 – Jun 6, 2019 · Past)
COO and General Counsel · Feb 4, 2021 – May 31, 2024 · Past
Amy Burroughs
Other companies: Tenaya Therapeutics, Inc. (Board Member · Since at least Oct 18, 2024)
Chief Executive Officer, Director · Since at least Feb 7, 2024
David Eric Strauss
Other companies: Bellicum Pharmaceuticals Inc (Sr Director, Corp Controller · Jan 8, 2020 – Dec 15, 2020 · Past)
Principal Accounting Officer · Feb 1, 2025 – Feb 1, 2025 · Past
All 17 people
PersonSeat
Emil Kuriakose
Other companies: Calithera Biosciences, Inc. (CHIEF MEDICAL OFFICER · Nov 5, 2021 – Jan 23, 2023 · Past)
Chief Medical Officer · Since at least Mar 10, 2024
Mark J Vignola
Other companies: Applied Therapeutics Inc (Chief Financial Officer · May 13, 2019 – May 13, 2019 · Past)
Chief Financial Officer · Feb 4, 2021 – Jan 2, 2025 · Past
Melita Sun Jung
Other companies: Structure Therapeutics, Inc. (Chief Business Officer · Feb 2, 2023 – Feb 7, 2023 · Past)
Chief Business Officer · Apr 22, 2024 – Jan 30, 2025 · Past
Ann Elizabeth TaylorDirector · Sep 28, 2021 – Jul 1, 2024 · Past
David A FellowsDirector · Since at least Jun 11, 2025
Erin QuirkPresident, Head of R&D · Feb 4, 2021 – Jan 23, 2024 · Past
Weidong ZhongChief Scientific Officer, Director · Feb 4, 2021 – Feb 4, 2021 · Past

Open People

Log in to ask 6ix AI your own questions about Terns Pharmaceuticals, Inc.